The Avicena Group Report issue

For profit Phase 3
Founded: Redwood City CA United States (1989)
Status: Defunct (2011)

Organization Overview

First Clinical Trial
2003
NCT00069186
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2003

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 3 Trials (1)

creatine (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Amyotrophic Lateral Sclerosis (Phase 3)

Motor Neuron Disease (Phase 3)

Sclerosis (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 1
  • # of Trial APIs: 1